IVD Medical Holding Limited (1931.HK)

HKD 1.53

(-4.38%)

Market Cap (In HKD)

2.48 Billion

Revenue (In HKD)

3.08 Billion

Net Income (In HKD)

238.16 Million

Avg. Volume

642.8 Thousand

Currency
HKD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.62-2.89
PE
-
EPS
-
Beta Value
-0.09
ISIN
KYG4977H1065
CUSIP
G4977H106
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Distribution
CEO
Mr. Kuk Sing Ho
Employee Count
-
Website
https://www.ivdholding.com
Ipo Date
2019-07-12
Details
IVD Medical Holding Limited, an investment holding company, distributes In vitro diagnostic (IVD) products in Mainland China and internationally. The company operates through three segments: Distribution Business, Maintenance Services, and Self-branded Products Business. It offers IVD analysers, reagents, and other consumables for various IVD testing categories, including hematology and body fluid, immunoassay, clinical chemistry, molecular, microbiology, and point-of-care testing. The company also provides haemostasis products; solution services to the clinical laboratories of hospitals; and maintenance services, such as maintenance and repair, installation, and end customer training services. In addition, it researches, develops, manufactures, and sells IVD analyzers and reagents under the IVD brand. The company offers its products to hospitals and healthcare institutions, logistics providers, and distributors. IVD Medical Holding Limited was founded in 1993 and is headquartered in Shanghai, the People's Republic of China.